Services & Capabilities
Cell line transformation, banking and characterization (cGMP if required)
53Biologics has proven experience producing a broad catalog of recombinant proteins (monoclonal, fusion, chimeric and fragment antibodies, biosimilars, enzymes, anticoagulants, vaccines, etc.) in a wide range of microbial expression systems such as yeast (Pichia, Saccharomyces), fungi (Trichoderma, Aspergillus and the revolutionary C1) or bacteria (E. coli, Bacillus, etc.), mammalian expression systems such as CHO, HEK and insect cells like S2.
During the last years, the company has developed an efficient molecular biology toolkit to improve protein expression and stability, that is now available for its clients.
53Biologics has experience in the Cell Bank generation and characterization, information required for the Investigational Medicinal Product Dossier (IMPD).